Search Results for "action"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for action. Results 561 to 570 of 1197 total matches.
Infliximab (Remicade) for Crohn's Disease
The Medical Letter on Drugs and Therapeutics • Feb 26, 1999 (Issue 1047)
, November 20,
1998).
MECHANISM OF ACTION — Tumor necrosis factor alpha (TNFα), a pro-inflammatory protein ...
Infliximab, a monoclonal antibody that inhibits tumor necrosis factor, has received an accelerated approval from the FDA for intravenous treatment of moderate to severe Crohn's disease refractory to other medical treatment.
Orlistat for Obesity
The Medical Letter on Drugs and Therapeutics • Jun 18, 1999 (Issue 1055)
OF ACTION — A pentanoic acid ester, orlistat binds to gastric and pancreatic lipases, inhibiting ...
Orlistat, a lipase inhibitor that decreases absorption of fat from the gastrointestinal tract, is now available for treatment of obesity.
Laser Hair Removal
The Medical Letter on Drugs and Therapeutics • Jul 30, 1999 (Issue 1058)
Aesth Dermatol Cosmet Surg, 1:3, 1999).
MECHANISM OF ACTION — Several laser systems are used for hair ...
A long-pulse ruby laser (EpiLaser), has been cleared by the FDA for use in "permanent hair reduction."
Spironolactone for Heart Failure
The Medical Letter on Drugs and Therapeutics • Sep 10, 1999 (Issue 1061)
than 2.5 mg/dl.
The most common adverse effects related to the anti-androgenic action ...
Spironolactone, an aldosterone receptor antagonist, has been FDA-approved for many years for treatment of edema, hypertension and primary hyperaldosteronism. Recently, it was reported to improve morbidity and mortality in patients with severe heart failure.
Phytoestrogens
The Medical Letter on Drugs and Therapeutics • Feb 21, 2000 (Issue 1072)
OF ACTION — Phytoestrogens generally act as weak estrogens, but may
also have antiestrogenic effects (J ...
Phytoestrogens, plant compounds that are converted to estrogens in the gut, are widely promoted as "natural"substitutes for estrogen in hormone replacement therapy.
Exemestane For Advanced Breast Cancer
The Medical Letter on Drugs and Therapeutics • Apr 17, 2000 (Issue 1076)
:61, 1996) and letrozole (Femara − Medical Letter, 40:43, 1998).
MECHANISM OF ACTION — Aromatase ...
The FDA has approved exemestane, an aromatase inhibitor, for the treatment of postmenopausal women with advanced breast cancer that has progressed during treatment with tamoxifen.
Ciclopirox (Penlac) Nail Lacquer for Onychomycosis
The Medical Letter on Drugs and Therapeutics • Jun 12, 2000 (Issue 1080)
, 1998). Its exact mechanism of action is unknown.
Less than 5% of a topical dose is absorbed ...
Ciclopirox nail lacquer (Penlac - Dermik) has been approved by the FDA for treatment of mild-to-moderate onychomycosis due to Trichophyton rubrum, without involvement of the lunula. The drug has been available for many years as a lotion and cream (Loprox) for treatment of cutaneous fungal infection
Rivastigmine (Exelon) For Alzheimer's Disease
The Medical Letter on Drugs and Therapeutics • Oct 02, 2000 (Issue 1089)
Letter 1997; 39:53).
MECHANISM OF ACTION — Cognitive deficits in Alzheimer’s disease ...
Rivastigmine tartrate (Exelon - Novartis), a carbamate-based cholinesterase inhibitor, is now being marketed for treatment of patients with dementia due to Alzheimer's disease.
Galantamine (Reminyl) for Alzheimer's Disease
The Medical Letter on Drugs and Therapeutics • Jun 25, 2001 (Issue 1107)
2001.
MECHANISM OF ACTION — Alzheimer’s disease is associated with diminished brain acetylcholine ...
Galantamine hydrobromide (Reminyl), a tertiary alkaloid and phenanthrene derivative extracted from daffodil bulbs, is now being marketed for oral treatment of mild to moderate Alzheimer's disease. Galantamine is the fourth acetylcholinesterase inhibitor approved for this indication.
Update on Glucosamine For Osteoarthritis
The Medical Letter on Drugs and Therapeutics • Dec 10, 2001 (Issue 1120)
, treat or prevent any disease.
MECHANISM OF ACTION — In vitro, glucosamine stimulates cartilage cells ...
Since the last Medical Letter article on glucosamine for osteoarthritis (vol.39, page 91, September 26, 1997), more data have become available. Glucosamine is available in US pharmacies and health food stores as sulfate, hydrochloride or n-acetyl salt.
